6.90
+0.73%
Close of 9 Nov 2026, in CNY
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Yabao Pharmaceutical Group Co
Its shares trade on Shanghai under the ticker 600351.SS. It has been listed since 26 September 2002. In the fiscal year to 31 December 2025, it reported revenue of CN¥2.24bn and net income of CN¥320.0m. At that date it held total assets of CN¥3.29bn and shareholders' equity of CN¥2.88bn.
Yabao Pharmaceutical Group Co., Ltd. engages in the development, production, and sale of pharmaceutical products. The company is headquartered in Beijing, Beijing. The company went IPO on 2002-09-26. The firm mainly provides light pastes, tablets, injections, capsules, oral liquids, bulk drugs and other pharmaceutical products. The firm is also engaged in the wholesaling and trading of pharmaceuticals. The firm distributes its products within domestic market and to overseas markets.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- Health Care
- Industry
- Pharmaceuticals
- Listed since
- 26 Sept 2002
- Employees
- 4,367
- Website
- yabao.com.cn ↗
Leadership
Pay as last reported
- Mr. Wuxian RenChairman of the Board, since 2020CN¥2.0m
- Mr. Wei RenVice Chairman of the Board, General Manager, since 2020CN¥1.6m
- Mr. Zhefeng ZuoChief Financial OfficerCN¥800,000
- Mr. Pengbo RenDeputy General Manager, Secretary of the Board, Director, since 2020CN¥1.3m
- Mr. Li HeDeputy General ManagerCN¥1.1m
- Mr. Jun LiangDeputy General ManagerCN¥1.1m
- Mr. Ke TangExecutive Deputy General ManagerCN¥1.3m
- Mr. Songjun LiDirector
- Mr. Yongan LiuDirector
- Mr. Bin WuDirector
- Mr. Minxuan CuiIndependent DirectorCN¥100,000
- Mr. Junyan LiuIndependent DirectorCN¥100,000
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 0
- Environment
- 0
- Social
- 0
- Governance
- 0
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Yabao Pharmaceutical Group employs 4367 employees in Beijing for pharmaceutical production.
- The company develops and sells light pastes, tablets, injections, and capsules in domestic and overseas markets.
- Yabao Pharmaceutical Group has a strong presence in the Chinese pharmaceutical sector with its diverse product portfolio.
Weaknesses
- Yabao Pharmaceutical Group's business is limited to pharmaceutical products without diversification into other sectors.
- The company's reliance on domestic market sales may pose risks in global economic fluctuations.
- Yabao's product range includes bulk drugs but lacks advanced biotechnology offerings.
Opportunities
- Expanding into overseas markets could increase Yabao Pharmaceutical Group's global presence and revenue streams.
- The growing demand for pharmaceuticals in China presents significant opportunities for Yabao's product lines.
- Yabao can leverage its existing distribution network to enter new segments within the Health Care industry.
Threats
- Competition from other Chinese pharmaceutical firms could impact Yabao's market share.
- Regulatory changes in the Chinese Health Care sector may affect production and distribution processes.
- Economic downturns in key overseas markets might reduce demand for Yabao's pharmaceutical products.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.